Bedaquiline Eliminates Bactericidal Activity of β-Lactams against Mycobacterium abscessus

Isoniazid bactericidal activity involves electron transport chain perturbation

(2019) Sheng Zeng et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

In vitro activity of the new β-lactamase inhibitors relebactam and vaborbactam in combination with β-lactams against Mycobacterium abscessus complex clinical isolates

(2019) Amit Kaushik et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Dual β-Lactam Combinations Highly Active against Mycobacterium abscessus Complex In Vitro

(2019) R. Pandey et al.   mBio

Select β-Lactam Combinations Exhibit Synergy against Mycobacterium abscessus In Vitro

(2019) Elizabeth Story-Roller et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Synergistic efficacy of β-lactam combinations against Mycobacterium abscessus pulmonary infection in mice.

(2019) Elizabeth Story-Roller et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

A White-Box Machine Learning Approach for Revealing Antibiotic Mechanisms of Action

(2019) Jason H. Yang et al.   CELL

NTM drug discovery: status, gaps and the way forward

(2018) Mu-Lu Wu et al.   DRUG DISCOVERY TODAY

Teicoplanin – Tigecycline Combination Shows Synergy Against Mycobacterium abscessus

(2018) Dinah B. Aziz et al.   Frontiers in Microbiology

The present state of the tuberculosis drug development pipeline

(2018) M Daben J Libardo et al.   CURRENT OPINION IN PHARMACOLOGY

Mycobacterial Cell Wall Synthesis Inhibitors Cause Lethal ATP Burst

(2018) Annanya Shetty et al.   Frontiers in Microbiology

In Vitro Susceptibility Testing of Bedaquiline Against Mycobacterium abscessus Complex

(2018) Barbara A. Brown-Elliott et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Preliminary Results of Bedaquiline as Salvage Therapy for Patients With Nontuberculous Mycobacterial Lung Disease

(2015) Julie V. Philley et al.   CHEST